Express registration and login! If you have a Facebook or LinkedIN account, use one of the buttons on the left to either login or create a new account.
WASHINGTON, DC USA (UroToday.com) - Written by Alberto A. Antunes, Urology; Francisco C. Carnevale, Vascular Interventional Radiology; and J. M. da Motta Leal Filho, Vascular Interventional Radiology; University of São Paulo Medical School, Brazil
WASHINGTON, DC USA (UroToday.com) - TURP is a suitable treatment for BPH, yet the relevant morbidity to the procedure and complications (an estimated 25 percent of benign prostatic hyperplasia (BPH) patients fail medication therapy or experience complication from TURP) are undesirable.
WASHINGTON, DC USA (UroToday.com) - Presented by Alberto A. Antunes, MD, Division of Urology, University of Sao Paulo Medical School, Sao Paulo, Brazil.
WASHINGTON, DC USA (UroToday.com) - Researchers at the University of California San Diego reported a two-fold prevalence of BPH with and a three-fold incidence in acute renal failure.
WASHINGTON, DC USA (UroToday.com) - Presented by J. Kellogg Parsons, MD, MHS, Associate Professor of Surgery at the Moores UCSD Comprehensive Cancer Center, San Diego, CA.
WASHINGTON, DC USA (UroToday.com) - During the AUA late breaking report on May 17, J. Kellogg Parsons, MD, reported findings from a seven year benign prostatic hyperplasia prevention study at the University of California San Diego.
WASHINGTON, DC USA (UroToday.com) - A 90 item questionnaire to assess surgical management of BPH was sent to urologists in the AUA database and the Veteran Health system;